{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:15:39Z","timestamp":1789910139352,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["14SDG18590020"],"award-info":[{"award-number":["14SDG18590020"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH Heart, Lung, and Blood Institute","award":["HL122199"],"award-info":[{"award-number":["HL122199"]}]},{"name":"NIH Heart, Lung, and Blood Institute","award":["HL110349"],"award-info":[{"award-number":["HL110349"]}]},{"name":"NIH Heart, Lung, and Blood Institute","award":["HL118989"],"award-info":[{"award-number":["HL118989"]}]},{"name":"NIH Heart, Lung, and Blood Institute","award":["HL129510"],"award-info":[{"award-number":["HL129510"]}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","award":["7231-12-1"],"award-info":[{"award-number":["7231-12-1"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH Biomedical Research Support Shared Instrumentation Grant","award":["S10RR029021"],"award-info":[{"award-number":["S10RR029021"]}]},{"name":"NIH Center Grant","award":["P30 EY01730"],"award-info":[{"award-number":["P30 EY01730"]}]}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.yjmcc.2016.09.001","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T20:18:51Z","timestamp":1475266731000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5348-864X","authenticated-orcid":false,"given":"Yong Seon","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Barbosa Marcondes","family":"de Mattos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Nabben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maengjo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Stephen C.","family":"Kolwicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2016.09.001_bb0005","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pcad.2005.02.010","article-title":"Epidemiology of diastolic heart failure","volume":"47","author":"Owan","year":"2005","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0015","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1161\/CIRCULATIONAHA.110.954388","article-title":"Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum","volume":"123","author":"Borlaug","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11886-014-0501-8","article-title":"Heart failure with preserved ejection fraction: current understandings and challenges","volume":"16","author":"Andersen","year":"2014","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0025","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCHEARTFAILURE.113.000887","article-title":"Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial","volume":"7","author":"Shah","year":"2014","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0030","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1161\/CIRCULATIONAHA.110.011031","article-title":"Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction","volume":"124","author":"Zile","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0035","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCHEARTFAILURE.113.000383","article-title":"Longitudinal changes in left ventricular stiffness: a community-based study","volume":"6","author":"Borlaug","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0040","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2011.1201","article-title":"Progression of left ventricular diastolic dysfunction and risk of heart failure","volume":"306","author":"Kane","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.18632\/aging.100881","article-title":"Rapamycin transiently induces mitochondrial remodeling to reprogram energy metabolism in old hearts","volume":"8","author":"Chiao","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0050","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCRESAHA.112.268128","article-title":"Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy","volume":"111","author":"Kolwicz","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0055","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.35.6.1183","article-title":"Angiotensin II and the heart: on the intracrine renin-angiotensin system","volume":"35","author":"De Mello","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/FJC.0b013e31815bb629","article-title":"Pravastatin attenuates left ventricular remodeling and diastolic dysfunction in angiotensin II-induced hypertensive mice","volume":"51","author":"Xu","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/CIRCHEARTFAILURE.112.966705","article-title":"Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction","volume":"5","author":"Mori","year":"2012","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0070","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","article-title":"Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure","volume":"108","author":"Dai","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0075","doi-asserted-by":"crossref","first-page":"H397","DOI":"10.1152\/ajpheart.00088.2013","article-title":"Substrain specific response to cardiac pressure overload in C57BL\/6 mice","volume":"305","author":"Garcia-Menendez","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0080","series-title":"Assessment of Cardiac Function and Energetics in Isolated Mouse Hearts Using 31P NMR Spectroscopy","author":"Kolwicz","year":"2010"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0085","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.2337\/db14-1943","article-title":"Enhancing cardiac triacylglycerol metabolism improves recovery from ischemic stress","volume":"64","author":"Kolwicz","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0090","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nprot.2012.058","article-title":"Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells","volume":"7","author":"Spinazzi","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0095","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1089\/ars.2012.4604","article-title":"Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease","volume":"19","author":"Dikalov","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3945\/an.112.003319","article-title":"Protein carbonylation, mitochondrial dysfunction, and insulin resistance","volume":"4","author":"Frohnert","year":"2013","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0003-9861(02)00446-0","article-title":"Selective inactivation of redox-sensitive mitochondrial enzymes during cardiac reperfusion","volume":"406","author":"Sadek","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0110","doi-asserted-by":"crossref","first-page":"11168","DOI":"10.1073\/pnas.94.21.11168","article-title":"Oxidative damage during aging targets mitochondrial aconitase","volume":"94","author":"Yan","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0115","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1152\/physiolgenomics.00057.2004","article-title":"Cardiac transcriptional response to acute and chronic angiotensin II treatments","volume":"18","author":"Larkin","year":"2004","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11010-008-9711-y","article-title":"Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation","volume":"311","author":"Akki","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0125","doi-asserted-by":"crossref","first-page":"44390","DOI":"10.1074\/jbc.M103826200","article-title":"Reactivation of peroxisome proliferator-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart","volume":"276","author":"Young","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0130","first-page":"H742","article-title":"Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts","volume":"267","author":"Allard","year":"1994","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0135","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.CIR.94.11.2837","article-title":"Fatty acid oxidation enzyme gene expression is downregulated in the failing heart","volume":"94","author":"Sack","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0140","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","article-title":"The failing heart relies on ketone bodies as a fuel","volume":"133","author":"Aubert","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0145","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/CIRCULATIONAHA.111.060889","article-title":"Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure","volume":"125","author":"Chokshi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0150","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/CIRCULATIONAHA.115.017545","article-title":"Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure","volume":"133","author":"Bedi","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0155","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/CIRCHEARTFAILURE.108.822627","article-title":"Prevalence of left ventricular diastolic dysfunction in a general population","volume":"2","author":"Kuznetsova","year":"2009","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0160","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1161\/01.CIR.99.17.2261","article-title":"Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism","volume":"99","author":"Lamb","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0165","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/01.CIR.96.4.1313","article-title":"Failure to maintain a low ADP concentration impairs diastolic function in hypertrophied rat hearts","volume":"96","author":"Tian","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0170","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/hh0901.089882","article-title":"Cardiac angiotensin II formation in the clinical course of heart failure and its relationship with left ventricular function","volume":"88","author":"Serneri","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0175","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.yjmcc.2013.07.010","article-title":"Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure","volume":"63","author":"Mori","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0180","doi-asserted-by":"crossref","first-page":"H550","DOI":"10.1152\/ajpheart.01176.2008","article-title":"Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint","volume":"296","author":"de Cavanagh","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0185","doi-asserted-by":"crossref","first-page":"H1103","DOI":"10.1152\/ajpheart.00636.2012","article-title":"ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4","volume":"304","author":"Mori","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0190","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1172\/JCI10947","article-title":"A novel mouse model of lipotoxic cardiomyopathy","volume":"107","author":"Chiu","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0195","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1161\/CIRCULATIONAHA.111.075978","article-title":"Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity","volume":"126","author":"He","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0200","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1172\/JCI63888","article-title":"Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes","volume":"122","author":"Russo","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0205","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0008-6363(99)00388-0","article-title":"Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy","volume":"45","author":"Jarreta","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0008-6363(01)00368-6","article-title":"Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure","volume":"52","author":"Marin-Garcia","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0215","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2337\/db07-0481","article-title":"Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins","volume":"56","author":"Boudina","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0220","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/sj.ijo.0801536","article-title":"Mechanism for obesity-induced increase in myocardial lipid peroxidation","volume":"25","author":"Vincent","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0230","first-page":"929","article-title":"Mitochondrial fatty acid oxidation and oxidative stress: lack of reverse electron transfer-associated production of reactive oxygen species","volume":"2010","author":"Schonfeld","year":"1797","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0235","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijcard.2012.09.123","article-title":"Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort study","volume":"163","author":"Fragasso","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0240","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2016.09.001_bb0245","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cardiores.2005.02.004","article-title":"Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure","volume":"66","author":"Lionetti","year":"2005","journal-title":"Cardiovasc. Res."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282816303455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282816303455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T01:16:10Z","timestamp":1568423770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282816303455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":49,"alternative-id":["S0022282816303455"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2016.09.001","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2016.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}